Lumigen, Inc. develops, manufactures and markets chemicals. It distributes chemiluminescent reagents for the clinical immunodiagnostics markets. The firm’s Life Diagnostics SPARCL Kits, Western Blotting, ELISA and Hydrogen Peroxide Detection. The company was founded by A. Paul Schaap in 1987 and is headquartered in Southfield, MI.

Alberta Health Services Its programs and services include addictions and substance abuse, allergies, asthma, blood and lymphatic system, bones, joints, and muscles, brain and nerves, cancer, complementary and alternative medicine, diabetes, digestion, environmental health, poison and toxicology, eyes and vision, food and nutrition, genes, chromosomes and genetic conditions, health system, heart and circulation, hormones and endocrine system, and immune system, as well as ear, nose, and throat. The company is headquartered in Edmonton, Canada.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Direct Genomics is making genomics an affordable part of everyday patient care. The company’s GenoCare instrument is the first single molecule sequencing system for clinical use. That simplifies sequencing by directly reading individual DNA and RNA molecule information from customer’s blood or tissue samples, delivering significant improvements in cost and speed. Established in 2012, Direct Genomics is headquartered in Shenzhen, China and backed by institutional and private investors.

MGI Tech is committed to enabling effective and affordable healthcare solutions for all. MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive, life-long solutions, its mission is to advance life science tools and lead digital health innovation.

Jiangsu Concos Medical Technology Co., Ltd., established on 2018-02-09, The scope of business includes,Class II,Three types of medical device research and development,Production,Sales;biological reagent,Biochemical reagents(Does not contain hazardous chemicals)and experimental equipment development,Production,Sales;biotechnology development,transfer,consult,to promote;Health Advisory(Does not include diagnosis and treatment);Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing Novizan Biotechnology Co., Ltd., established on 2012-03-16, Business scope includes biological reagents,Enzyme reagent research and development,Production,Sales,Technical Consulting and Technical Services;Biochemical reagents and consumables,Electrical Equipment,electronics sales;Self-operated and agent import and export business of various commodities and technologies(Except where the state restricts enterprises to operate or prohibits the import and export of commodities and technologies).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Experimental analysis instrument sales;Manufacturing of experimental analysis instruments;Mechanical equipment research and development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Shenzhen Yibeikehua Biotechnology Co., Ltd., established on 2019-08-21, Business scope includes general business items:Biotechnology,Biological and biochemical products,Research and development of biomedical engineering and related technical services,technical consulting,technology transfer;software development,computer,Software and Auxiliary Equipment(In addition to special products for computer information system security)promotion of;Bioinformatics software development and sales;Industrial Investment;Realtor;Self-operated and agent import and export business of various commodities and technologies;Enterprise Marketing Planning,consult,Conference organization and training;Wholesale and sales of monitoring and treatment equipment;wholesale sales;General Machinery Sales;Machinery and Equipment Leasing;computer retail,software retail,Medical equipment rental service,Sales of electrical machinery and equipment,Sales of chemical reagents and auxiliaries(Monitor Chemicals,Excluding hazardous chemicals) ;Special Equipment Sales.,The licensing program is:biological reagent(Does not contain hazardous chemicals)research and development,Technical service and technology transfer,production and sales;Clinical Laboratory Services;medical diagnosis,medical diagnosis,Monitoring and treatment equipment retail;Monitor Chemical Manufacturing;medical diagnosis,Monitoring and treatment equipment manufacturing,Manufacturing of medical laboratory equipment and appliances,Production of medical electronic equipment(The specific production range is<Medical Device Manufacturing Enterprise License>prevail) ;Medical supplies and equipment retail(Does not contain drugs and medical devices) ;Chemical Reagent and Auxiliary Manufacturing(Monitor Chemicals,Excluding hazardous chemicals) ;Manufacturing of special chemicals(Monitor Chemicals,Excluding hazardous chemicals) ;Manufacturing of Information Chemicals(Monitor Chemicals,Excluding hazardous chemicals) ;Manufacturing of other non-hazardous basic chemical raw materials;Manufacturing and sales of experimental analysis instruments.

Thermo Fisher Scientific Baltics UAB, part of Thermo Fisher Scientific, Inc., is a Lithuanian company located in Vilnius that operates as a biotechnology company that develops and manufactures products for global markets life science research and diagnostics.

Nisshin Flour Milling, Inc. manufactures and sells wheat flour. It supplies wheat flour and premix products for manufacturing use, as well as other related products such as wheat bran, wheat germ and rye. The company was founded in 1908 and is located in Tokyo, Japan

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Hunan Aikerui Biological Engineering Co., Ltd., established on 2018-07-02, Business scope includes research and development of biological reagents,Production,Sales;Research and development of raw materials for inspection and testing,Production,Sales;Biotechnology Development Services,consult,communication service,transfer service;laboratory consumables,Sales of plastic products;Chemical Reagents and Auxiliaries(Monitor Chemicals,Excluding hazardous chemicals)manufacturing,Sales;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu GenScript Biotechnology Co., Ltd., established on 2016-08-31, Business scope includes biopharmaceutical products,Preparation of products related to bioengineering, biomedical engineering, and bioagricultural engineering,Sales and related technical research and development,technology transfer,Technical Services(restricted class,Except prohibited),Experimental equipment and consumables,biological reagent(In addition to dangerous goods),Sales of Class I Medical Devices,Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Engineering and Technology Research and Experimental Development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Sales of new organic active materials;Chemical product sales(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

JMDNA is a high-tech enterprise focusing on new technology research and clinical application in the field of women and children. It provides comprehensive, individualized, and precise genetic testing services for medical institutions and industry partners.

Resolution Bioscience is pioneering next-generation cancer diagnostics that enable physicians to tailor treatments for each patient using only a blood test — a liquid biopsy. Resolution Bioscience's proprietary molecular analytics platform interrogates cell-free DNA for actionable information that, until now, has only been accessible through invasive biopsy procedures. Resolution Bioscience has developed over 50 focused panels and is currently working on companion diagnostics to support therapeutic approvals. Resolution Bioscience is dedicated to improving cancer outcomes through a suite of clinical tests to guide the selection of targeted therapies and monitor their effectiveness over time.

Rikemeng (Qingdao) Bioengineering Co., Ltd., established on 2018-10-12, Business scope includes research and development of bacteriophage,production and sales;Biotechnology Extension Services;New material technology promotion service;food,cosmetic,medicine,veterinary medicine,Feed technology research and development,Production and Information Consulting,Ecological agriculture technology development and service(The above scope is carried out in accordance with the license issued by the competent department to carry out business activities);Intelligent Technology,Energy and Environmental Technology,New Material Technology,Biological Technology,Medical technology research and development;Network technology research and development;Internet information service;account Serive;Food processing technology consulting and transfer;Import and export of goods and technology(law,Except for items prohibited by administrative regulations,law,Projects restricted by administrative regulations can only be operated after obtaining a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)